Table Table AII.
Incidence of Nondrug‐Treated Hypertension at First Follow‐Up According to Groupings Defined by Quintiles of Blood Pressure and baPWV at Baseline Examination a
| Population | Variable | Q1 | Q2 | Q3 | Q4 | Q5 | Trend for P |
|---|---|---|---|---|---|---|---|
| Total | baPWV | 32 (7.49) | 45 (10.51) | 70 (16.71) | 90 (21.74) | 128 (32.16) | <.0001 |
| SBP | 29 (6.47) | 36 (9.94) | 82 (18.85) | 121 (23.63) | 97 (29.48) | <.0001 | |
| DBP | 37 (9.07) | 54 (12.92) | 100 (20.08) | 67 (18.93) | 107 (26.23) | <.0001 | |
| PP | 42 (10.05) | 49 (13.00) | 77 (16.01) | 102 (22.32) | 95 (26.91) | <.0001 | |
| MAP | 27 (6.21) | 53 (13.12) | 72 (16.67) | 92 (22.01) | 121 (30.48) | <.0001 | |
| Male | baPWV | 21 (10.19) | 31 (14.90) | 51 (25.00) | 59 (29.21) | 70 (35.90) | <.0001 |
| SBP | 23 (9.91) | 19 (14.62) | 60 (23.26) | 90 (33.83) | 40 (31.01) | <.0001 | |
| DBP | 29 (13.94) | 34 (18.78) | 69 (25.65) | 33 (22.60) | 67 (31.75) | .002 | |
| PP | 30 (14.35) | 31 (19.25) | 52 (20.72) | 75 (30.49) | 44 (29.73) | <.0001 | |
| MAP | 22 (10.33) | 34 (17.35) | 45 (21.95) | 65 (31.71) | 66 (33.67) | <.0001 | |
| Female | baPWV | 11 (4.98) | 14 (6.36) | 19 (8.84) | 31 (14.62) | 58 (28.57) | <.0001 |
| SBP | 6 (2.78) | 17 (7.33) | 22 (12.43) | 31 (12.60) | 57 (28.50) | <.0001 | |
| DBP | 8 (4.00) | 20 (8.44) | 31 (13.54) | 34 (16.35) | 40 (20.30) | <.0001 | |
| PP | 12 (5.74) | 18 (8.33) | 25 (10.87) | 27 (12.80) | 51 (24.88) | <.0001 | |
| MAP | 5 (2.25) | 19 (9.13) | 27 (11.89) | 27 (12.68) | 55 (27.36) | <.0001 |
Abbreviations: baPWV, brachial‐ankle pulse wave velocity; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure. Values are expressed as number (percentage). aA total of 67 participants taking antihypertensive agents were excluded.